Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosisElena M. Kaftanovskaya, Alexander I. Agoulnik, Kenneth J. Wilson et al.|The FASEB Journal|2019Cited by 35
Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule AgonistsXin Hu, Alexander I. Agoulnik, Courtney Myhr et al.|Biochemistry|2016Cited by 29
Human Relaxin Receptor Is Fully Functional in Humanized Mice and Is Activated by Small Molecule Agonist ML290Elena M. Kaftanovskaya, Alexander I. Agoulnik, Mariluz Soula et al.|Journal of the Endocrine Society|2017Cited by 24
Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290Zaohua Huang, Alexander I. Agoulnik, Courtney Myhr et al.|Frontiers in Endocrinology|2015Cited by 21
Small molecule allosteric agonist of relaxin receptor ML290 demonstrates antifibrotic properties in liver fibrosisElena M. Kaftanovskaya, Alexander I. Agoulnik, Hooi Hooi Ng et al.|Endocrine Abstracts|2019Cited by 1